Abstract 2001: A Conformational Disease Component of Lowe Syndrome Pathology Rescued by Allosteric Activator Candidates von Lee, Jennifer, Mundre, Swati, Pacheco, Andres, Ramadesikan, Swetha, Black, Adrianna, Skiba, Lisette, Aguilar, Ruben

Volltext

Abstract 4022: Integrin β1 regulates doxorubicin resistance in breast cancer via FAK-mediated activation of ERK1 pathway von Das, Subhayan, Jena, Bikash Ch, Mundre, Swati, Parekh, Aditya, Rajesh, Y, Mitra, Pralay, Mandal, Mahitosh

Volltext

A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance von Das, Subhayan, Kundu, Moumita, Hassan, Atif, Parekh, Aditya, Jena, Bikash Ch, Mundre, Swati, Banerjee, Indranil, Yetirajam, Rajesh, Das, Chandan K., Pradhan, Anjan K., Das, Swadesh K., Emdad, Luni, Mitra, Pralay, Fisher, Paul B., Mandal, Mahitosh

Volltext

Knockdown of STIP1 inhibits the invasion of CD133‑positive cancer stem‑like cells of the osteosarcoma MG63 cell line via the PI3K/Akt and ERK1/2 pathways von Wang, Jian-Hua, Gong, Chen, Guo, Feng-Jin, Zhou, Xiao, Zhang, Ming-Sheng, Qiu, Hong, Chao, Teng-Fei, Liu, Yang, Qin, Liang, Xiong, Hui-Hua

Volltext